Viewing Study NCT05288504


Ignite Creation Date: 2025-12-24 @ 9:06 PM
Ignite Modification Date: 2026-01-02 @ 4:39 AM
Study NCT ID: NCT05288504
Status: COMPLETED
Last Update Posted: 2024-09-05
First Post: 2022-03-08
Is NOT Gene Therapy: True
Has Adverse Events: True

Brief Title: A Study to Evaluate the Safety and Efficacy of AVTX-002 for the Treatment of Poorly Controlled Non-Eosinophilic Asthma.
Sponsor: Avalo Therapeutics, Inc.
Organization:

Key Dates - Follows AllAPIJSON File Order

Start Date: 2022-02-24
Start Date Type: ACTUAL
Primary Completion Date: 2023-05-11
Primary Completion Date Type: ACTUAL
Completion Date: 2023-05-11
Completion Date Type: ACTUAL
First Submit Date: 2022-03-08
First Submit QC Date: None
Study First Post Date: 2022-03-21
Study First Post Date Type: ACTUAL
Results First Submit Date: 2024-05-08
Results First Submit QC Date: None
Results First Post Date: 2024-09-05
Results First Post Date Type: ACTUAL
Results First Post QC Date: None
Results First Post QC Date Type: None
Disp First Submit Date: None
Disp First Submit QC Date: None
Disp First Post Date: None
Disp First Post Date Type: None
Last Update Submit Date: 2024-08-29
Last Update Post Date: 2024-09-05
Last Update Post Date Type: ACTUAL